Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin | Zendy

Keitaro Senoo | Zendy; Gregory Y.H. Lip | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin

Author(s) -

Keitaro Senoo,

Gregory Y.H. Lip

Publication year - 2016

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.116.013173

Subject(s) - medicine , atrial fibrillation , warfarin , stroke (engine) , hazard ratio , cardiology , acenocoumarol , proportional hazards model , confidence interval , mechanical engineering , engineering

Female patients have higher risk for stroke than male patients in nonanticoagulated atrial fibrillation patients, but limited data are available on sex differences in stroke and bleeding outcomes among patients with anticoagulated atrial fibrillation on warfarin, especially in relation to quality of anticoagulation control, as reflected by the time in therapeutic range (TTR).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research